Multiparameteric PET-MR Assessment of Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer: PET, MR, PET-MR and Tumor Texture Analysis: A Pilot Study
Purpose: Patients with locally advanced rectal cancer (LARC) achieving pathologic complete response (pCR) to neoadjuvant chemoradiotherapy (CRT) have significantly improved long term survival. Preoperative detection of pCR may enable a conservative therapeutic approach in some patients. The purpose of the current prospective pilot study was to assess multiparametric qualitative and quantitative MR, PET, PET-MR and tumor texture features in predicting pCR to CRT in patients with LARC. Material and Methods: Eighteen LARC patients underwent staging with FDG-PET and MR-rectum and 15 had post-CRT restaging. Response was assessed qualitatively and quantitatively. SUV (tumor/background), SUV/ADC, and tumor texture parameters derived via machine learning algorithms (MLA) from PET and multiple MR sequences and were correlated with histopathology. Results: A third of patients had pCR. Sensitivity, specificity & accuracy of PET, MR and combined PET-MR were 90, 60, & 80; 90, 20 & 66.7; 90, 80 & 86.7, respectively. Differences did not reach statistical significance. Quantitatively, only tumor-muscle (SUV/ADC) ratio improved prediction of pCR. Of all texture features assessed using MLA, only the classifier trained on pre-treatment PET was significant (p = 0.034; accuracy, 92.8%). Combined PET and MR texture features did not improve performance. Conclusion: Combined PET-MR may improve specificity compared with PET or MR alone, although this needs to be validated in a larger cohort. Tumor to muscle SUV/ADC ratios post-therapy and texture features on baseline PET show promise in improving prediction of pCR post-CRT in LARC.
References
[1]
Maas, M., Nelemans, P.J., Valentini, V., Das, P., Rödel, C., Kuo, L.J., et al. (2010) Long-Term Outcome in Patients with a Pathological Complete Response after Chemoradiation for Rectal Cancer: A Pooled Analysis of Individual Patient Data. Lancet Oncology, 11, 835-844. http://dx.doi.org/10.1016/S1470-2045(10)70172-8
[2]
Zorcolo, L., Rosman, A.S., Restivo, A., Pisano, M., Nigri, G.R., Fancellu, A., et al. (2012) Complete Pathologic Response after Combined Modality Treatment for Rectal Cancer and Long-Term Survival: A Meta-Analysis. Annals of Surgical Oncology, 19, 2822-2832. http://dx.doi.org/10.1245/s10434-011-2209-y
[3]
Martin, S.T., Heneghan, H.M. and Winter, D.C. (2012) Systematic Review and Meta-Analysis of Outcomes Following Pathological Complete Response to Neoadjuvant Chemoradiotherapy for Rectal Cancer. British Journal of Surgery, 99, 918-928. http://dx.doi.org/10.1002/bjs.8702
[4]
Habr-Gama, A., Perez, R., Proscurshim, I. and Gama-Rodrigues, J. (2010) Complete Clinical Response after Neoadjuvant Chemoradiation for Distal Rectal Cancer. Surgical Oncology Clinics of North America, 19, 829-845.
http://dx.doi.org/10.1016/j.soc.2010.08.001
[5]
Maas, M., Beets-Tan, R.G.H., Lambregts, D.M., Lammering, G., Nelemans, P.J., Engelen, S.M., et al. (2011) Wait-and-See Policy for Clinical Complete Responders after Chemoradiation for Rectal Cancer. Journal of Clinical Oncology, 29, 4633-4640. http://dx.doi.org/10.1200/JCO.2011.37.7176
[6]
Patel, U.B., Blomqvist, L.K., Taylor, F., George, C., Gurthrie, A., Bees, N., et al. (2012) MRI after Treatment of Locally Advanced Rectal Cancer: How to Report Tumor Response—The MERCURY Experience. American Journal of Roentgenology, 199, W486-W495. http://dx.doi.org/10.2214/ajr.11.8210
[7]
Patel, U.B., Taylor, F., Blomqvist, L., George, C., Evans, H., Tekkis, P., et al. (2011) Magnetic Resonance Imaging-Detected Tumor Response for Locally Advanced Rectal Cancer Predicts Survival Outcomes: MERCURY Experience. Journal of Clinical Oncology, 29, 3753-3760. http://dx.doi.org/10.1200/JCO.2011.34.9068
[8]
Mandard, A., Dalibard, F., Mandard, J., Marnay, J., Henry-Amar, M., Petiot, J.F., et al. (1994) Pathologic Assessment of Tumor Regression after Preoperative Chemoradiotherapy of Esophageal Carcinoma. Clinicopathologic Correlations. Cancer, 73, 2680-2686.
http://dx.doi.org/10.1002/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C
[9]
Ryan, R., Gibbons, D., Hyland, J.M., Treanor, D., White, A., Mulcahy, H.E., et al. (2005) Pathological Response Following Long-Course Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer. Histopathology, 47, 141-146. http://dx.doi.org/10.1111/j.1365-2559.2005.02176.x
[10]
Tixier, F., Le Rest, C.C., Hatt, M., Albarghach, N., Pradier, O., Metges, J.P., et al. (2011) Intratumor Heterogeneity Characterized by Textural Features on Baseline 18F-FDG PET Images Predicts Response to Concomitant Radiochemotherapy in Esophageal Cancer. Journal of Nuclear Medicine, 52, 369-378.
http://dx.doi.org/10.2967/jnumed.110.082404
[11]
Haralick, M.H., Shanmugam, K. and Dinstein, I. (1973) Textural Features for Image Classification. IEEE Transactions on Systems, Man, and Cybernetics, 3, 610-621. http://dx.doi.org/10.1109/TSMC.1973.4309314
[12]
Amadasun, M. and King, R. (1989) Texural Features Corresponding to Textural Properties. IEEE Transactions on Systems, Man, and Cybernetics, 19, 1264-1274. http://dx.doi.org/10.1109/21.44046
[13]
Loh, H.H., Leu, G. and Luo, R.C. (1988) The Analysis of Natural Textures Using Run Length Features. IEEE Transactions on Industrial Electronics, 35, 323-328. http://dx.doi.org/10.1109/41.192665
[14]
Thibault, G., Fertil, B., Navarro, C. and Pereira, S. (2009) Texture Indexes and Gray Level Size Zone Matrix Application to Cell Nuclei Classification. Pattern Recognition and Information Processing (PRIP), 140-145.
[15]
Chang, C.C. and Lin, C.J. (2011) LIBSVM: A Library for Support Vector Machines. ACM Transactions on Intelligent Systems and Technology, 2, 1-27. http://dx.doi.org/10.1145/1961189.1961199
[16]
Li, Y.L., Wu, L.M., Chen, X.X., Delproposto, Z., Hu, J.N. and Xu, J.R. (2014) Is Diffusion-Weighted MRI Superior to FDG-PET or FDG-PET/CT in Evaluating and Predicting Pathological Response to Preoperative Neoadjuvant Therapy in Patients with Rectal Cancer? Journal of Digestive Diseases, 15, 525-537.
http://dx.doi.org/10.1111/1751-2980.12174
[17]
Rakheja, R., De Mello, L., Chandarana, H., Jackson, K., Geppert, C., Faul, D., et al. (2013) Comparison of the Accuracy of PET/CT and PET/MRI Spatial Registration of Multiple Metastatic Lesions. American Journal of Roentgenology, 201, 1120-1123. http://dx.doi.org/10.2214/AJR.13.11305
[18]
Park, H., Wood, D., Hussain, H., Meyer, C.R., Shah, R.B., Johnson, T.D., et al. (2012) Introducing Parametric Fusion PET/MRI of Primary Prostate Cancer. Journal of Nuclear Medicine, 53, 546-551.
http://dx.doi.org/10.2967/jnumed.111.091421
[19]
Gevaert, O., Xu, J., Hoang, C.D., Leung, A.N., Xu, Y., Quon, A., et al. (2012) Non-Small Cell Lung Cancer: Identifying Prognostic Imaging Biomarkers by Leveraging Public Gene Expression Microarray Data—Methods and Preliminary Results. Radiology, 264, 397-396. http://dx.doi.org/10.1148/radiol.12111607
[20]
Karlo, C., Paolo, P.L., Chaim, J., Hakimi, A.A., Ostrovnaya, I., Russo, P., et al. (2013) Radiogenomics of Clear Cell Carcinoma: Association between CT Imaging Features and Mutations. Radiology, 270, 464-471.
http://dx.doi.org/10.1148/radiol.13130663
[21]
Kumar, V., Gu, Y., Basu, S., Berglund, A., Eschrich, S.A., Schabath, M.B., et al. (2012) Radiomics: The Process and the Challenges. Magnetic Resonance Imaging, 30, 1234-1248. http://dx.doi.org/10.1016/j.mri.2012.06.010